drugset / Trial / NCT03976713

Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD

NCT03976713

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to establish the treatment scheme of Bufei Yishen granule for GOLD stage 3 or 4 chronic obstructive pulmonary disease (COPD), reducing acute exacerbation, improving exercise capacity and forming high quality evidence.

Timeline

Start
2019-06
Primary completion
2020-06
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bufeiyishen granule Traditional medicine (herbal / TCM) Oral
Background Tiotropium Other / unclassified 18 ug Inhaled